Long Term, Registry-Based, Prospective, Post-Authorization Safety Study Evaluating Adverse Events of Special Interest in Patients with Highly Active Relapsing Multiple Sclerosis Newly Started on Cladribine Tablets − CLARION
Titel:
Long Term, Registry-Based, Prospective, Post-Authorization Safety Study Evaluating Adverse Events of Special Interest in Patients with Highly Active Relapsing Multiple Sclerosis Newly Started on Cladribine Tablets − CLARION
Auteur:
Butzkueven, Helmut Korhonen, P. Hillert, Jan Trojano, M Aydemir, A. Magyari, Melinda Khanfir, H Pinuaga, C Sabidó, Meritxell